Vinithra Varadarajan, MD MPH

22 posts

Vinithra Varadarajan, MD MPH banner
Vinithra Varadarajan, MD MPH

Vinithra Varadarajan, MD MPH

@vinithrav1

PGY 3 IM resident | Cardiovascular researcher| Imaging research @hopkinsheart #internalmedicine #cardiology #publichealth

Katılım Mayıs 2018
227 Takip Edilen65 Takipçiler
Dr. Datta M.D. (Radiology) M.B.B.S. 🇮🇳
🚨 Fantastic opportunity for young medical graduates (Post MBBS) to work on a global AI for healthcare initiative and help coordinate one of the largest clinical AI evaluation projects in India. 🇮🇳 ➡️ We’re looking for a full-time Clinical Research Lead (post-MBBS) to drive MOOVE-India, part of a worldwide effort to rigorously evaluate medical AI with clinicians at the center. ✅ You’ll be working closely with our team at @KCDH_A @AshokaUniv and supervised by few of the world's top healthcare AI leaders: 🔥 @anniehartley_ Prof. Annie Hartley, founder of LiGHT Lab and creator of Meditron, the world's first open source medical LLM (@EPFL @HarvardChanSPH) 🔥 @AnuragAgrawalMD Prof. Anurag Agrawal, one of India’s leading physician-scientists 🔥 Prof. Mona Duggal, Director @icmr_nirdhds spearheading ICMR’s Digital Health Research ecosystem 🚨 THIS IS A FULL TIME ROLE (HYBRID OPTION AVAILABLE - BUT WILL INVOLVE TRAVEL) - ONLY POST MBBS! 🚨 ⬇️ If you are interested, comment here and our team will reach out to you with details!
Dr. Datta M.D. (Radiology) M.B.B.S. 🇮🇳 tweet media
English
72
17
92
12.4K
Vinithra Varadarajan, MD MPH retweetledi
JAMA
JAMA@JAMA_current·
Muvalaplin, a small-molecule lipoprotein(a) inhibitor, produced substantial reductions in lipoprotein(a) levels in patients at high risk of cardiovascular events. #AHA24 ja.ma/3Z9M0bV
JAMA tweet media
English
0
14
35
9.5K
CardioNerds
CardioNerds@CardioNerds·
🚨 Submit your fascinating cardiology cases to the @CardioNerds Case Reports! 🩺 ✨ Share medical stories that bring together everyone from students to faculty in this engaging podcast series. 🌍 Let’s learn together & democratize CV medicine! cardionerds.com/cardionerds-ca…
English
1
7
16
2.3K
Vinithra Varadarajan, MD MPH
Today is a special day as we launched our internal medicine residency program's evidence based, practice changing monthly newsletter "Journal Junket"- for residents and by residents!
Vinithra Varadarajan, MD MPH tweet media
English
0
0
2
203
Vinithra Varadarajan, MD MPH retweetledi
Madeline Simon
Madeline Simon@MSharpMed·
Kicking off ACC.24 finally meeting some of my fellow Women in Cardiology IM Cohort members in-person! 🤗
Madeline Simon tweet mediaMadeline Simon tweet media
Atlanta, GA 🇺🇸 English
0
5
22
1.2K
Vinithra Varadarajan, MD MPH retweetledi
Dr. Martha Gulati ♥️🫀❤️‍🩹🇨🇦
#ACC24 VICTORION-INITIATE Trial 🫀Pt with ASCVD, Max tol statin +LDL>70 randomized to #inclisiran 1st strategy🆚 UC 🫀Inclisiran 1st: more effective than UC practices at absolute LDL-C ⤵️ & achieving guideline-recommended LDL 🫀UC: few patients got to target LDL goal😢 🫀<1/3 💃🏻
Dr. Martha Gulati ♥️🫀❤️‍🩹🇨🇦 tweet mediaDr. Martha Gulati ♥️🫀❤️‍🩹🇨🇦 tweet mediaDr. Martha Gulati ♥️🫀❤️‍🩹🇨🇦 tweet mediaDr. Martha Gulati ♥️🫀❤️‍🩹🇨🇦 tweet media
English
2
45
133
15.7K
Vinithra Varadarajan, MD MPH retweetledi
Dr. Martha Gulati ♥️🫀❤️‍🩹🇨🇦
EMPACT MI trial #LBCT #ACC24 presented by @JavedButler1 🫀SGLT2i in AMI & ⤴️ risk of HF: efficacy & safety 🫀75% Male (where are the women?!) 🫀10% reduction in primary endpoint HHF/death but NS BUT significant 23% ⤵️ in HF🏥 🚨So does this become part of our AMI Tx?
Dr. Martha Gulati ♥️🫀❤️‍🩹🇨🇦 tweet mediaDr. Martha Gulati ♥️🫀❤️‍🩹🇨🇦 tweet mediaDr. Martha Gulati ♥️🫀❤️‍🩹🇨🇦 tweet mediaDr. Martha Gulati ♥️🫀❤️‍🩹🇨🇦 tweet media
Atlanta, GA 🇺🇸 English
5
65
170
24.2K
Vinithra Varadarajan, MD MPH retweetledi
Dr Roxana Mehran
Dr Roxana Mehran@Drroxmehran·
RelieveHF neutral, big interaction with regard to HF with reduced (benefit)vs preserved (harm)EF!!! Much to think about Interesting patient population with lower filling pressures at rest, very sick patient population @GreggWStone @ACCinTouch
Dr Roxana Mehran tweet mediaDr Roxana Mehran tweet mediaDr Roxana Mehran tweet mediaDr Roxana Mehran tweet media
English
1
16
76
6.9K
Vinithra Varadarajan, MD MPH retweetledi
Mamas A. Mamas
Mamas A. Mamas@mmamas1973·
#EMPACT-MI empaglifozocin did not reduceall cause mortality or HF hospitalisation post AMI, despite high risk heart failure criteria for inclusion #ACC24 Heart failure hospitalisations reduced though. would one really expect a reduction in mortality?
Mamas A. Mamas tweet mediaMamas A. Mamas tweet mediaMamas A. Mamas tweet media
English
9
48
137
20.4K